Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has issued an announcement.
Jiangsu Recbio Technology Co., Ltd. has announced its 2024 Annual General Meeting scheduled for June 20, 2025, where various resolutions will be considered, including financial reports, profit distribution plans, and changes in business scope. The meeting’s outcomes could significantly impact the company’s strategic direction and stakeholder interests, particularly with resolutions on share issuance and amendments to the Articles of Association.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the biotechnology industry, focusing on medical technology and innovation.
Average Trading Volume: 94,656
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.01B
For detailed information about 2179 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue